About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
15 May,2023
Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index
On May 12, MSCI, a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2023 Index Review for the MSCI Equity Indexes....
more
27 Apr,2023
Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions
Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. ("Hicicare"). With t...
more
30 Mar,2023
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million
On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, hereinafter referred to as the "Company") released its annual financial results for 2022. During the reporting peri...
more
22 Mar,2023
Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, "the Company" ), one of the leading players in the neuro- and peripheral-vascular interventional medical device market in China, announ...
more
16 Dec,2022
Zylox-Tonbridge Receives Approval to Launch ZYLOX Octoplus™ IVC Filter from NMPA
On December 2nd, 2022, Zylox-Tonbridge (2190.HK, “the Company”) announced that the company was granted marketing approval by China’s National Medical Products Administration (NMPA) for its self-dev...
more
19 Aug,2022
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22
On August 15, Zylox-Tonbridge (2190.HK, “the Company”) released its 2022 interim results.
more
